Docetaxel (TaxotereR) is active in non-small-cell lung cancer: A phase II trial of the EORTC early clinical trials group (ECTG)

Lung Cancer ◽

10.1016/0169-5002(95)96428-x ◽

1995 ◽

Vol 12 (1-2) ◽

pp. 148

Keyword(s):

Lung Cancer ◽

Clinical Trials ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Cell Lung Cancer ◽

Phase Ii Trial ◽

Small Cell Lung

Download Full-text

Single agent activity of rhizoxin in non-small-cell lung cancer: A phase II trial of the EORTC early clinical trials group

Lung Cancer ◽

10.1016/0169-5002(96)84393-5 ◽

1996 ◽

Vol 15 (1) ◽

pp. 155

Keyword(s):

Lung Cancer ◽

Clinical Trials ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Cell Lung Cancer ◽

Phase Ii Trial ◽

Single Agent ◽

Small Cell Lung

Download Full-text

Taxotere is active in small cell lung cancer (SCLC) a phase II trial of the eortc early clinical trials group (ECTG)

European Journal of Cancer ◽

10.1016/0959-8049(93)91473-x ◽

1993 ◽

Vol 29 ◽

pp. S154 ◽

Author(s):

JF Smyth ◽

A Bowman ◽

I Smith ◽

C Sessa ◽

S Kaye

Keyword(s):

Lung Cancer ◽

Clinical Trials ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Cell Lung Cancer ◽

Phase Ii Trial ◽

Small Cell Lung

Download Full-text

Tallimustine is inactive in patients with previously treated small cell lung cancer. A phase II trial of the National Cancer Institute of Canada Clinical Trials Group

Lung Cancer ◽

10.1016/0169-5002(95)00600-1 ◽

1996 ◽

Vol 15 (3) ◽

pp. 367-373 ◽

Author(s):

J. Viallet ◽

D. Stewart ◽

F. Shepherd ◽

J. Ayoub ◽

Y. Cormier ◽

...

Keyword(s):

Lung Cancer ◽

Clinical Trials ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Cell Lung Cancer ◽

National Cancer Institute ◽

Phase Ii Trial ◽

Small Cell Lung ◽

Previously Treated

Download Full-text

Phase II Trial of 13-cis-Retinoic Acid Plus Interferon in Non-Small-Cell Lung Cancer: For the National Cancer Instit ute of Canada Clinical Trials Group

JNCI Journal of the National Cancer Institute ◽

10.1093/jnci/86.4.306 ◽

1994 ◽

Vol 86 (4) ◽

pp. 306-309 ◽

Author(s):

A. Arnold ◽

J. Ayoub ◽

L. Douglas ◽

P. Hoogendoorn ◽

L. Skingley ◽

...

Keyword(s):

Lung Cancer ◽

Clinical Trials ◽

Retinoic Acid ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Cell Lung Cancer ◽

Phase Ii Trial ◽

Small Cell Lung

Download Full-text

Erratum to “Tallimustine is inactive in patients with previously treated small cell lung cancer. A phase II trial of the National Cancer Institute of Canada Clinical Trials Group” [Lung Cancer 15 (1996) 367–373]

Lung Cancer ◽

10.1016/s0169-5002(97)00667-3 ◽

1997 ◽

Vol 17 (1) ◽

pp. 179

Keyword(s):

Lung Cancer ◽

Clinical Trials ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Cell Lung Cancer ◽

National Cancer Institute ◽

Phase Ii Trial ◽

Small Cell Lung ◽

Previously Treated

Download Full-text

Docetaxel (TaxotereTM) is active in non-small-cell lung cancer: a phase II trial of the EORTC early clinical trials group (ECTG)

British Journal of Cancer ◽

10.1038/bjc.1994.311 ◽

1994 ◽

Vol 70 (2) ◽

pp. 384-387 ◽

Author(s):

T Cerny ◽

◽

S Kaplan ◽

N Pavlidis ◽

P Schöffski ◽

...

Keyword(s):

Lung Cancer ◽

Clinical Trials ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Cell Lung Cancer ◽

Phase Ii Trial ◽

Small Cell Lung

Download Full-text

Single agent activity of rhizoxin in non-small-cell lung cancer: a phase II trial of the EORTC Early Clinical Trials Group

British Journal of Cancer ◽

10.1038/bjc.1996.70 ◽

1996 ◽

Vol 73 (3) ◽

pp. 403-405 ◽

Author(s):

S Kaplan ◽

AR Hanauske ◽

N Pavlidis ◽

U Bruntsch ◽

A te Velde ◽

...

Keyword(s):

Lung Cancer ◽

Clinical Trials ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Cell Lung Cancer ◽

Phase Ii Trial ◽

Single Agent ◽

Small Cell Lung

Download Full-text

Phase II Trial of Thalidomide, Irinotecan and Gemcitabine in Chemonaive Patients with Advanced Non-Small Cell Lung Cancer

Cancer Investigation ◽

10.1080/07357900801944856 ◽

2009 ◽

pp. 1-1

Author(s):

A. R. Jazieh ◽

R. Komrokji ◽

A. Gupta ◽

S. Patil ◽

D. Flora ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Cell Lung Cancer ◽

Phase Ii Trial ◽

Small Cell Lung

Download Full-text

P48.05 Anlotinib Plus Platinum-Etoposide in 1st-Line Treatment of Extensive-Stage Small-Cell Lung Cancer: A Single-Arm Phase II Trial

Journal of Thoracic Oncology ◽

10.1016/j.jtho.2021.01.875 ◽

2021 ◽

Vol 16 (3) ◽

pp. S501

Author(s):

P. Deng ◽

H. Yang ◽

C. Chen ◽

C. Hu ◽

L. Cao ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Cell Lung Cancer ◽

Phase Ii Trial ◽

Line Treatment ◽

Small Cell Lung ◽

Extensive Stage

Download Full-text

OA01.06 DETERRED: Phase II Trial Combining Atezolizumab Concurrently with Chemoradiation Therapy in Locally Advanced Non-Small Cell Lung Cancer

Journal of Thoracic Oncology ◽

10.1016/j.jtho.2018.08.237 ◽

2018 ◽

Vol 13 (10) ◽

pp. S320-S321 ◽

Author(s):

S. Lin ◽

X. Lin ◽

D. Clay ◽

L. Yao ◽

I. Mok ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Cell Lung Cancer ◽

Phase Ii Trial ◽

Locally Advanced ◽

Chemoradiation Therapy ◽

Small Cell Lung

Download Full-text